BioCentury
ARTICLE | Company News

Hospital del Mar, University of Turin, Biocartis deal

May 2, 2016 7:00 AM UTC

Hospital del Mar, via its Hospital del Mar Medical Research Institute (IMIM) tech transfer office, and the university granted Biocartis exclusive rights to EGFR resistance mutations in colorectal can...